Deshaun N. is a Director of Clinical Program - CAR-T Cell Therapy Oncology at Pepromene Bio. They possess expertise in clinical trials, ich gcp, stakeholder management, cro, electronic data capture and 27 more skills. Colleagues describe them as "DeShaun consistently and enthusiastically was a source of expertise and a champion for my career growth. Her clinical trial knowledge spanned across cross-functional teams and was crucial to the ongoing success of our programs. Aside from her professional skillset, DeShaun helped ensure positive team morale via her passion in leadership.", "I had the privilege of managing DeShaun Noakes during her tenure as Associate Director of Clinical Operations at Caribou Biosciences, where she consistently demonstrated exceptional leadership, expertise, and a dedication to operational excellence. DeShaun successfully drove critical milestones, including completing the first dose level ahead of schedule and achieving major project goals for pivotal programs like CB-010 and CB-011. Her ability to streamline long-term follow-up protocols and advance site activations highlighted her strategic thinking and problem-solving skills. What truly sets DeShaun apart is her leadership style. She fostered collaboration across departments, mentored team members, and built strong relationships with investigators, stakeholders, and Key Opinion Leaders. Her knack for championing clear communication among CROs, vendors, and internal teams ensured seamless execution and study success. DeShaun’s adaptability, operational insight, and commitment to high standards make her an invaluable asset to any organization. She embodies professionalism, accountability, and a genuine passion for advancing clinical operations to achieve transformative outcomes. I highly recommend DeShaun for any leadership role in clinical operations—her impact is not only measurable in results but also in the strong, inclusive culture he cultivates wherever he goes.", and "I have worked with DeShaun on extremely complex clinical trials in cell therapy in hematologic malignancies, including AML, that require thoughtful attention to detail and strong collaboration with KOLs and external experts. She is experienced, knowledgeable, meticulous, and above all, a team player. DeShaun is an asset to any team she is a part of!"